Published in J Immunol on March 01, 1967
Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro. J Exp Med (1973) 1.83
Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro. J Virol (1968) 1.36
Effect of phytohaemagglutinin on the immune response. Immunology (1968) 0.81
Phytohemagglutinin stimulation of enhanced immunoglobulin G production in mice inoculated with type III pneumococcal polysaccharide. Infect Immun (1978) 0.77
Studies on the interaction of the Sophora japonica lectin and concanavalin A with erythrocytes and lymphocytes. Immunology (1976) 0.75
Effect of phytohaemagglutinin on Ehrlich ascites carcinoma. Br J Cancer (1969) 0.75
Effects of phytohemagglutinin on humoral antibody response, delayed hypersensitivity, and homograft rejection. Surgery (1970) 0.75
Autoimmune thyroiditis in young and old mice: differential effect of high doses of PHA. Immunology (1982) 0.75
Studies on the effect of phytohaemagglutinin and anti-lymphocytic globulin on the primary humoral response to sheep erythrocytes and bovine serum albumin in hooded and Wistar rats. Clin Exp Immunol (1970) 0.75
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
The transfer of allergic thyroiditis in histocompatible guinea pigs by lymph node cells. J Immunol (1967) 1.48
Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res (1991) 1.31
Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br J Cancer (1980) 1.29
Inhibition of human natural killer activity by cyclosporin A. Transplantation (1981) 1.22
Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res (1996) 1.14
Factors Influencing the Production of Tetanus Toxin: Gaseous Products of Growth. J Bacteriol (1948) 1.13
Retinal and uveal inflammation in monkeys following inoculation with homologous retinal antigen. Arch Ophthalmol (1969) 1.11
CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur J Immunol (1995) 1.11
Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. J Natl Cancer Inst (1978) 1.10
Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors. Int J Cancer (1979) 1.10
Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors. Oncogene (2008) 1.06
Human mature macrophages mediate antibody-dependent cellular cytotoxicity on tumour cells. Transplantation (1977) 1.06
Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun (1984) 1.05
Acute and chronic autoimmune encephalomyelitis: age, strain, and sex dependency. The importance of the source of antigen. Proc Soc Exp Biol Med (1969) 1.00
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity. Br J Cancer (1992) 0.99
Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res (1987) 0.99
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies. Int J Cancer (1993) 0.96
Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data. Cancer Treat Rev (1977) 0.95
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells. Br J Cancer (1992) 0.94
Novel anthracycline analogs. Cancer Treat Rev (1990) 0.94
Characterization of the immunostimulants levamisole and tetramisole. Eur J Cancer (1975) 0.94
Anorexia and cancer in animals and man. Cancer Treat Rev (1980) 0.92
Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer (2013) 0.90
Polymer conjugates. Pharmacokinetic considerations for design and development. Clin Pharmacokinet (1994) 0.90
In vitro generation of nonspecific suppressor cells and their characterization. Transplantation (1979) 0.89
Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors. Int J Biol Markers (2002) 0.89
Autoimmune encephalomyelitis and ocular lesions in monkeys sensitized during the neonatal period. Science (1966) 0.89
Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int J Cancer (1980) 0.88
Autoimmune chorioretinitis in rhesus monkeys. Science (1968) 0.88
Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice. J Natl Cancer Inst (1979) 0.88
Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat. Cancer Chemother Pharmacol (1991) 0.86
Immunodepressant activity and 6-mercaptopurine levels after administration of 6-mercaptopurine and azathioprine. Transplantation (1973) 0.86
Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity: Brief communication. J Natl Cancer Inst (1977) 0.85
Childhood liposarcoma: a single-institutional twenty-year experience. Pediatr Hematol Oncol (1999) 0.84
Large granular lymphocytes from murine blood and intestinal epithelium: comparison of surface antigens, natural killer activity, and morphology. Clin Immunol Immunopathol (1985) 0.84
Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma. Eur J Cancer (1981) 0.83
Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1. Oncogene (2000) 0.83
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in an intensive treatment program for children with Ewing's sarcoma. Haematologica (2001) 0.83
Serum enzymatic activities in experimental lead poisoning. Enzyme (1971) 0.83
Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol (2000) 0.83
A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection. Cancer Res (1976) 0.83
The isolation of antilymphocytic antibodies. Transplantation (1970) 0.81
The unique interaction with immunity of FCE 24517, an antitumor drug with a novel mode of action. Int J Immunopharmacol (1992) 0.81
Suppression of graft-versus-host disease and antibody formation by phytohemagglutinin. Transplantation (1969) 0.80
On the nature of blocking factors and their lymphoid target cells in an allogeneic tumor system. Eur J Cancer (1975) 0.80
Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity. Br J Cancer (1977) 0.80
Adoptive autoimmune encephalomyelitis in inbred guinea pigs: immunological and histological aspects. Science (1968) 0.80
A case of relapsing glioblastoma multiforme responding to vinorelbine. J Neurooncol (2006) 0.79
Cancer chemotherapeutics as immunomodulators. Springer Semin Immunopathol (1985) 0.79
Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response. Eur J Cancer (1975) 0.79
Antigenic changes of L5178Y lymphoma after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in vivo. J Natl Cancer Inst (1976) 0.79
Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell-mediated cytotoxicity in mice. Biomedicine (1980) 0.79
Ftorafur: a self-limiting source of 5-fluorouracil? Cancer Chemother Pharmacol (1979) 0.79
Effect of phenobarbital on cyclophosphamide cytotoxic activity and pharmacokinetics in mice. Tumori (1977) 0.79
Esterase activity in the skeletal muscles of dystrophic and normal mice. Biomedicine (1981) 0.79
Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice. J Immunol (1978) 0.79
A characterization of the activity of alpha-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound. Cancer Chemother Pharmacol (1980) 0.79
Non-ALC peripheral T-cell lymphomas in children: report on two cases and review of the literature. Haematologica (2000) 0.78
Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review. Pediatr Hematol Oncol (2013) 0.78
The immunomodulatory activity of the plant proteins Momordica charantia inhibitor and pokeweed antiviral protein. Int J Immunopharmacol (1983) 0.78
Combined effects of antineoplastic agents and anti-lymphoma allograft reactions. Eur J Cancer (1980) 0.78
Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice. Int J Immunopharmacol (1980) 0.78
Preliminary characterization in mice of the effect of isoprinosine on the immune system. Cancer Treat Rep (1978) 0.78
The effect of acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral antibody production and cell-mediated activities in mice. Arch Toxicol Suppl (1980) 0.78
The immunological activity of plant toxins used in the preparation of immunotoxins--II. The immunodepressive activity of gelonin. Int J Immunopharmacol (1985) 0.78
Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates. Cancer Treat Rep (1984) 0.77
Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate. Cancer Treat Rep (1978) 0.77
Selected pharmacologic characteristics of idarubicin and idarubicinol. Leukemia (1992) 0.77
K cell activity in ovarian cancer patients given chemotherapy. Eur J Cancer (1979) 0.77
Modulation by suramin of NK and monocytic cell-mediated cytotoxicity in human and murine cells. Int J Immunopharmacol (1988) 0.77
A murine ovarian tumor with unique metastasizing capacity. Eur J Cancer (1981) 0.77
Dansyl N-acetyl glucosamine as a precursor of fluorescent chitin: a method to detect fungal cell wall inhibitors. J Antibiot (Tokyo) (1997) 0.77
Suppression of mitogen responses and graft-versus-host reaction by splenocytes from mice bearing Lewis lung carcinoma. J Natl Cancer Inst (1978) 0.77
SCT for Wilms' tumour. Bone Marrow Transplant (2008) 0.76
Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice. Eur J Cancer (1976) 0.76
Dechloro teicoplanin antibiotics. J Antibiot (Tokyo) (1989) 0.76
The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice. Transplantation (1976) 0.76
Heterogeneity of the interaction of anticancer agents with the immune system and its possible relevance in chemoimmunotherapy. Oncology (1980) 0.76
The immunodepressive and hematotoxic activities of N-trifluoro-acetyl-adriamycin-14-valerate. Eur J Cancer (1980) 0.76
Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment. Br J Cancer (2005) 0.75
Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL). Med Pediatr Oncol (2001) 0.75
Effect of immunomodulators on thymocyte suppressive activity in mice. Eur J Cancer (1978) 0.75
Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms. Eur J Cancer (1976) 0.75
The heterogeneity of the interaction between cancer chemotherapeutic agents and host resistance mechanisms. Recent Results Cancer Res (1980) 0.75
The attacker: target-cell ratio and serum effects on in vitro cell-mediated immunity. J Natl Cancer Inst (1975) 0.75
Effect of the combination of Corynebacterium parvum and levamisole on murine tumors. Eur J Cancer (1977) 0.75
Steroid contraceptive agents and immunological reactivity in experimental animals. Biomedicine (1976) 0.75
Selective antimetastatic treatment--current status and future prospects. Cancer Treat Rev (1974) 0.75
Characterization of methotrexate recovered from the urine of high dose patients for the purpose of clinical re-use. Eur J Cancer (1978) 0.75
The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system. Eur J Cancer (1976) 0.75
Combination chemo-immunotherapy with adriamycin in experimental tumor systems. Eur J Cancer (1977) 0.75
New technique for the measurement of ascites tumor cell numbers. Cancer Chemother Rep (1975) 0.75
Autoimmune encephalomyelitis and hemorrhagic retinal disease in neonatal, infant, juvenile, and adult monkeys. J Neuroimmunol (1985) 0.75
Some examples of interactions between drugs in cancer chemotherapy. Antibiot Chemother (1971) (1978) 0.75
Concerning the influence of non-specific brain-stem structures on the vegetative functions of the brain in cerebral pathology. Electroencephalogr Clin Neurophysiol (1969) 0.75
Vasculo-occlusive retinopathy in experimental allergic encephalomyelitis. Arch Ophthalmol (1967) 0.75
Macrophage-mediated cytostatic activity on tumour cells after treatment with Triton WR 1339. Eur J Cancer (1978) 0.75
The immunostimulatory activity of 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazole [3,2-alpha]-benzimidazole-2-acetic acid (NSC 208828). Eur J Cancer (1978) 0.75
Characterization of the immunostimulatory activity of levamisole. Boll Ist Sieroter Milan (1974) 0.75